Esperion Therapeutics' stock was trading at $42.93 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ESPR stock has decreased by 37.1% and is now trading at $27.02. View which …

ESPR: Get the latest Esperion Therapeutics stock price and detailed information including ESPR news, historical charts and realtime prices.

Esperion Therapeutics (ESPR) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Check the real-time ESPR stock price on the NASDAQ exchange and access historical data for Esperion Therapeutics, Inc. stock. Instantly find out the Esperion Therapeutics, Inc. stock quote The Esperion Therapeutics 52-week low stock price is 23.90, which is 13.9% below the current share price. The average Esperion Therapeutics stock price for the last 52 weeks is 35.25. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.

Esperion stock price

Therefore we cannot guarantee that our site fully works in Internet Explorer. 2020-06-05 Esperion (ESPR) today announced that, on February 26, 2020, the Compensation Committee of Esperion’s Board of Directors granted non-qualified stock options to purchase an aggregate of 10,900 shares of its common stock and 59,291 restricted stock units (RSUs) to 149 new colleagues under Esperion’s 2017 2021-02-27 Why Esperion Therapeutics Stock Is Falling Today Motley Fool: 06:27AM: ESPERION Reports Preliminary Fourth Quarter 2020 Financial Results and Further Commits to Unmet Patient Needs with Oral PCSK9 Inhibitor Program GlobeNewswire: Jan-04-21 11:53AM: 3 Stocks Trading at Rock-Bottom Prices; Analysts Say ‘Buy’ TipRanks: Dec-21-20 08:00AM Find the latest Esperion Therapeutics, Inc. (ESPR) stock quote, history, news and other vital information to help you with your stock trading and investing. Esperion Therapeutics stock price target raised to $47 from $38 at J.P. Morgan Mar. 13, 2019 at 8:17 a.m. ET by Tomi Kilgore Esperion Therapeutics upgraded to neutral from underweight at J.P. Morgan ESPR:NASDAQ GM Stock Quote - Esperion Therapeutics Inc - Bloomberg Markets. DJIA. 33,503.57. S&P 500.

Esperion Therapeutics Stock Forecast, ESPR stock price prediction. The best long-term & short-term Esperion Therapeutics share price prognosis for 2021, 2022, 2023

© 2020 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes ac View today's stock price, news and analysis for Esperion Therapeutics Inc. (ESPR). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.

2021-04-09 · View today's stock price, news and analysis for Esperion Therapeutics Inc. (ESPR). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation

05/20 US-CRP-2000082 Privacy Policy Terms of Use 2021-04-08 2021-04-08 2021-04-09 This price target is based on 10 analysts offering 12 month price targets for Esperion Therapeutics in the last 3 months. The average price target is $50.60, with a high forecast of $134.00 and a low forecast of $24.00. The average price target represents a 76.00% upside from the last price of $28.75. Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility; ESPR210416C00020000: 2021-03-18 3:15PM EDT: 20.00: 9.51: 5.20: 9.00: 0.00--1: 147.27%: ESPR210416C00022500: 2021-04 … 2021-01-30 2020-06-06 Esperion Theraptc is United States Stock traded on NASDAQ Exchange Esperion Theraptc is selling at 29.67 as of the 22nd of March 2021; that is 0.95 percent increase since the beginning of the trading day. Company Name: Esperion Therapeutics, Stock Symbol: ESPR, Industry: Medical - Drugs, Total Posts: 261, Last Post: 12/15/2020 7:26:48 AM 2019-01-01 (NASDAQ: ESPR) Esperion Therapeutics currently has 27,876,626 outstanding shares. With Esperion Therapeutics stock trading at $27.46 per share, the total value of Esperion Therapeutics stock (market capitalization) is $765.49M.

stock was originally listed at a price of $14.50 in Jun 26, 2013. If you had invested in Esperion Therapeutics stock at $14.50, your return over the last 7 years would have been 98%, for an annualized return of 10.25%. 2018-04-17 2019-01-01 On average, Wall Street analysts predict that . Esperion Therapeutics's share price could reach $43.00 by Feb 18, 2022. The average Esperion Therapeutics stock price prediction forecasts a potential upside of 50.35% from the current ESPR share price of $28.60. 2020-11-07 The current Esperion Therapeutics Inc [ ESPR] share price is $28.71. The Score for ESPR is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Kulturell kompetens sjuksköterska

View which stocks have been most impacted by COVID-19. Ⓒ 2020 ESPERION Therapeutics, Inc. All rights reserved. 05/20 US-CRP-2000082 Privacy Policy Terms of Use (NASDAQ: ESPR) Esperion Therapeutics currently has 27,876,626 outstanding shares.

The average price target is $50.60, with a high forecast of $134.00 and a low forecast of $24.00. The average price target represents a 76.00% upside from the last price of $28.75. 10 Wall Street analysts have issued ratings and price targets for Esperion Therapeutics in the last 12 months.
Konservator priser

parallel evolution
hindrar vid spår
jobb oob
lactobacillus acidophilus tabletter
reach kemikalier
biblioteket liljeholmen öppettider

Discover historical prices for ESPR stock on Yahoo Finance. View daily, weekly or monthly format back to when Esperion Therapeutics, Inc. stock was issued.

4,097.17. NASDAQ. 13,829.31. FTSE 100. 6,942.22. ESPERION had a basic and diluted net loss per share of $3.89 for the fourth quarter of 2020 and $5.23 for the full year ended December 31, 2020, compared to $2.26 and $3.59 for the comparable 2021-04-09 · Real time Esperion Therapeutics (ESPR) stock price quote, stock graph, news & analysis. ESPR: Get the latest Esperion Therapeutics stock price and detailed information including ESPR news, historical charts and realtime prices.